Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case–Control Study

Background: To investigate the association between proton pump inhibitor (PPI) exposure and a risk of type 2 diabetes mellitus (T2DM) among patients with upper gastrointestinal disease (UGID). Method: We conducted a case–control study from Taiwan’s National Health Insurance Research Database between...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Hsin-Ya, Liang, Chih-Sung, Tsai, Shih-Jen, Chen, Tzeng-Ji, Chu, Che-Sheng, Chen, Mu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316003/
https://www.ncbi.nlm.nih.gov/pubmed/35886592
http://dx.doi.org/10.3390/ijerph19148739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316003/
https://www.ncbi.nlm.nih.gov/pubmed/35886592
http://dx.doi.org/10.3390/ijerph19148739

Ejemplares similares